We provide the health care industry with one stop short/long term solutions to Research and Development, Clinical Research Operations, Regulatory Submissions, Independent Data Monitoring Committees (DMC), Central IRB Services, independent central Data and Safety Monitoring Board (DSMB), Data Capture and Management, Clinical Data Base Design and Maintenance, as well as expertise in Technology Transfer, Strategic Planning, Compliance, Clinical Research Business Development, and Global Partnerships and Alliances.

At KamGen Consulting Inc., one of our  core competencies is Oncology, and we are experienced in global, multi-center studies in hematology. We also have served our clients with First in Man and Phase I - Phase IV studies in Neuroscience, Cardio Vascular and Men's Health.

Our DMC group specializes in hematology. We have conducted clinical studies of lymphoma, and non-Hodgkin's lymphoma (NHL) in the past, with the focus on registrational and phase II trials in lymphoma and solid tumors. Our staff, adult and pediatric, hematologists, hemato-oncologists, and
bio-statisticians are world class leaders in their filed. We provide unsurpassed quality of work to our clients in pharmaceutical industry.

Our specialty is to custom design our care according to the needs of our clients, and their business model. We are a full service Clinical Global Business Development, Operations, Management, and Research company. Serving the Patients is the core of our company's culture.


We have international scientific, business and cultural experience, as well as access to niche markets. The alliances that we have formed over the years could not have been obtained by any means, other than professionalism, honesty, and unparalleled customer satisfaction.